493 related articles for article (PubMed ID: 11943824)
1. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice.
Bondolfi L; Calhoun M; Ermini F; Kuhn HG; Wiederhold KH; Walker L; Staufenbiel M; Jucker M
J Neurosci; 2002 Jan; 22(2):515-22. PubMed ID: 11784797
[TBL] [Abstract][Full Text] [Related]
3. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes.
Hernandez D; Sugaya K; Qu T; McGowan E; Duff K; McKinney M
Neuroreport; 2001 May; 12(7):1377-84. PubMed ID: 11388415
[TBL] [Abstract][Full Text] [Related]
4. Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice.
Boncristiano S; Calhoun ME; Howard V; Bondolfi L; Kaeser SA; Wiederhold KH; Staufenbiel M; Jucker M
Neurobiol Aging; 2005 May; 26(5):607-13. PubMed ID: 15708435
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease.
Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K
Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177
[TBL] [Abstract][Full Text] [Related]
6. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic neurodegeneration in an Alzheimer mouse model overexpressing amyloid-precursor protein with the Swedish-Dutch-Iowa mutations.
Foidl BM; Do-Dinh P; Hutter-Schmid B; Bliem HR; Humpel C
Neurobiol Learn Mem; 2016 Dec; 136():86-96. PubMed ID: 27670619
[TBL] [Abstract][Full Text] [Related]
8. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.
Perez SE; Dar S; Ikonomovic MD; DeKosky ST; Mufson EJ
Neurobiol Dis; 2007 Oct; 28(1):3-15. PubMed ID: 17662610
[TBL] [Abstract][Full Text] [Related]
10. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
11. Selective loss of basal forebrain cholinergic neurons in APP770 transgenic mice.
Li H; Shen X
Chin Med J (Engl); 2000 Nov; 113(11):1040-2. PubMed ID: 11776121
[TBL] [Abstract][Full Text] [Related]
12. Persistent innervation of the rat neocortex by basal forebrain cholinergic neurons despite the massive reduction of cortical target neurons. II. Neurochemical analysis.
Minger SL; Davies P
Exp Neurol; 1992 Aug; 117(2):139-50. PubMed ID: 1354164
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
15. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
[TBL] [Abstract][Full Text] [Related]
16. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
[TBL] [Abstract][Full Text] [Related]
17. Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.
Perez SE; He B; Muhammad N; Oh KJ; Fahnestock M; Ikonomovic MD; Mufson EJ
Neurobiol Dis; 2011 Feb; 41(2):338-52. PubMed ID: 20937383
[TBL] [Abstract][Full Text] [Related]
18. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
[TBL] [Abstract][Full Text] [Related]
20. Basal forebrain magnocellular cholinergic systems are damaged in mice following neonatal hypoxia-ischemia.
Northington FJ; Kratimenos P; Turnbill V; Flock DL; Asafu-Adjaye D; Chavez-Valdez R; Martin LJ
J Comp Neurol; 2022 Jun; 530(8):1148-1163. PubMed ID: 34687459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
